Tezos
1.2457
09-January-25 09:06:24
realtime
Instruments
-0.0743
-5.63%
Today's range
1.2457 - 1.4617
ISIN
FXXTZUSD
Source
GEMN
-
FY2024 EPS Estimates for Enbridge Increased by Analyst
09 Jan 2025 08:36:14 By Buzz FX
-
TransAlta FY2024 EPS Increased by National Bank Financial
09 Jan 2025 08:36:14 By Buzz FX
-
FY2024 EPS Estimate for Capstone Copper Reduced by Analyst
09 Jan 2025 08:36:14 By Buzz FX
-
Analysts Offer Predictions for TSE:PPL FY2024 Earnings
09 Jan 2025 08:36:14 By Buzz FX
-
Atb Cap Markets Reduces Earnings Estimates for Lycos Energy
09 Jan 2025 08:36:14 By Buzz FX
-
Analysts Offer Predictions for Ivanhoe Mines FY2024 Earnings
09 Jan 2025 08:36:14 By Buzz FX
-
FY2024 EPS Estimates for TransAlta Reduced by Analyst
09 Jan 2025 08:36:14 By Buzz FX
-
EMERGING MARKETS: CEEMEA FX Price Signal Summary - USDZAR Bull Cycle Intact
09 Jan 2025 08:31:24 By Buzz FX
-
iA Financial Co. Inc. (TSE:IAG) Receives Consensus Recommendation of "Moderate Buy" from Analysts
09 Jan 2025 08:31:13 By Buzz FX
-
Great-West Lifeco Inc. (TSE:GWO) Receives Average Recommendation of "Hold" from Analysts
09 Jan 2025 08:31:13 By Buzz FX
-
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Consensus Recommendation of "Hold" by Analysts
09 Jan 2025 08:31:13 By Buzz FX
-
09 Jan 2025 08:31:13 By Buzz FX
-
Embraer and Textron Stocks: Off-the-Radar Winners in Aerospace
09 Jan 2025 08:31:13 By Buzz FX
-
Experian (OTCMKTS:EXPGY) Upgraded by Royal Bank of Canada to "Moderate Buy" Rating
09 Jan 2025 08:31:13 By Buzz FX
-
Alimentation Couche-Tard (TSE:ATD) Upgraded to Strong-Buy at National Bank Financial
09 Jan 2025 08:31:13 By Buzz FX
-
Nektar Therapeutics (NASDAQ:NKTR) Stock Rating Upgraded by B. Riley
09 Jan 2025 08:31:13 By Buzz FX
-
Bank of America (NYSE:BAC) Raised to Strong-Buy at Hsbc Global Res
09 Jan 2025 08:31:13 By Buzz FX
-
Truist Financial (NYSE:TFC) Stock Rating Upgraded by Hsbc Global Res
09 Jan 2025 08:31:13 By Buzz FX
-
Canadian Pacific Kansas City (TSE:CP) Upgraded to "Strong-Buy" at Wolfe Research
09 Jan 2025 08:31:13 By Buzz FX
-
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Upgraded by Barclays to "Strong-Buy" Rating
09 Jan 2025 08:31:13 By Buzz FX